GleamWall
中文EN

LMAT LEMAITRE VASCULAR INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1158895 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.8%
TTM net income YoY18.7%
TTM EPS YoY18.5%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR32.4%

Margins

Gross margin72.0%
Operating margin27.7%
Net margin23.5%
FCF margin24.9%
EBITDA margin31.7%

Returns

ROE15.6%
ROA10.1%
ROIC (approx.)15.3%
Asset turnover0.43x

Leverage & solvency

Liabilities / assets34.1%
Debt / equity0.00x
Current ratio14.60x
Interest coverage14.35x

Cash quality & payout

Operating cash flow / net income1.20x
Accruals ratio-2.1%
Payout ratio34.2%
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$67.97M$70.38M$66.55M$64.45M$61.05M$64.23M$59.87M$55.72M
Cost of revenue$19.27M$19.62M$18.16M$18.26M$15.09M$19.26M$18.45M$17.13M
Gross profit$48.70M$50.76M$48.40M$46.19M$45.95M$44.97M$41.42M$38.59M
R&D expense$4.42M$4.85M$4.06M$3.53M$2.97M$3.54M$4.09M$3.62M
SG&A expense$12.08M$11.11M$12.05M$10.39M$10.75M$10.40M$10.49M$9.49M
Operating income$17.70M$20.40M$17.77M$18.83M$20.31M$16.14M$12.63M$12.85M
Interest expense$1.30M$1.30M$1.30M$1.30M$1.30M$1.30M$1.29M$205,000
Pretax income$19.67M$22.19M$19.67M$20.30M$22.57M$18.07M$14.24M$14.02M
Income tax$4.65M$5.14M$3.99M$4.72M$5.21M$4.29M$3.23M$2.84M
Net income$15.02M$17.05M$15.68M$15.58M$17.36M$13.78M$11.01M$11.18M
EBITDA$20.58M$23.06M$20.40M$21.44M$22.93M$18.79M$15.18M$15.33M
EPS (basic)0.660.750.69—0.770.610.49—
EPS (diluted)0.650.740.68—0.750.600.48—
Dividends declared per share0.250.250.250.200.200.200.200.16
Weighted avg. shares (diluted)23.07M24.53M23.03M—24.39M22.89M22.90M—
Balance sheet
Cash & equivalents$27.49M$26.62M$26.85M$28.24M$25.49M$27.18M$25.34M$25.61M
Short-term investments$362.23M$349.62M$340.38M$330.88M$317.56M$292.31M$277.21M$274.11M
Receivables$35.88M$35.68M$35.77M$33.61M$32.42M$36.54M$35.11M$30.06M
Current assets$505.51M$488.30M$477.82M$468.23M$452.02M$430.13M$408.11M$402.19M
PP&E, net$30.46M$29.59M$28.54M$27.00M$26.46M$25.36M$25.11M$24.80M
Goodwill$65.94M$65.94M$65.94M$65.94M$65.94M$65.94M$65.94M$65.94M
Intangibles$29.30M$30.54M$31.67M$33.09M$31.71M$33.15M$34.40M$35.82M
Total assets$656.03M$640.55M$629.53M$615.69M$598.07M$577.59M$556.01M$551.82M
Current liabilities$34.62M$29.93M$33.37M$36.32M$33.29M$30.82M$24.75M$30.61M
Total liabilities$223.90M$220.21M$222.90M$222.17M$219.15M$214.91M$208.43M$214.53M
Shareholders' equity$432.13M$420.34M$406.62M$393.52M$378.92M$362.69M$347.57M$337.29M
Shares outstanding22.88M22.86M22.85M22.77M———22.55M
Cash flow statement
Operating cash flow$21.99M$15.96M$15.09M$23.16M$28.76M$20.29M$9.04M$15.18M
Capital expenditure$2.33M$2.31M$2.78M$1.78M$2.28M$1.34M$1.38M$2.04M
Free cash flow$19.66M$13.65M$12.31M$21.38M$26.48M$18.95M$7.66M$13.14M
Investing cash flow-$16.21M-$11.08M-$13.12M-$16.82M-$27.45M-$16.35M-$4.32M-$173.89M
Financing cash flow-$4.97M-$5.05M-$3.22M-$3.59M-$2.95M-$2.76M-$5.24M$164.08M
Depreciation & amortization$2.88M$2.66M$2.62M$2.60M$2.61M$2.65M$2.55M$2.48M
Stock-based compensation$2.03M$1.94M$2.09M$2.10M$1.74M$1.94M$2.05M$1.74M
Dividends paid$5.72M$5.72M$5.71M$4.54M$4.54M$4.52M$4.52M$3.60M
Share buybacks$0$17,000$460,000$1.22M$0$4,000$601,000$1.35M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.